Last reviewed · How we verify

NCT01950897

Muscle Tissue Bank for Muscular Dystrophy

Completed Last updated 26 April 2022
What this trial tests

trial in Muscular Dystrophies in 21 participants. Completed in 9 June 2015.

Timeline
24 August 2005
Primary endpoint
30 January 2015
9 June 2015

Quick facts

Lead sponsorWake Forest University Health Sciences
StatusCompleted
Study typeOBSERVATIONAL
Enrollment21
Start date24 August 2005
Primary completion30 January 2015
Estimated completion9 June 2015
Sites1 location across United States

Conditions studied

Sponsor

Wake Forest University Health Sciences

Who can join

6 and older, any sex, with Muscular Dystrophies or Muscular Dystrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This protocol proposes to establish gene expression profiles of muscular dystrophies for correct diagnosis and for development of experimental therapies for these diseases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Muscular Dystrophies

Currently open trials in the same condition.

Other Wake Forest University Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01950897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing